Extensively Drug-Resistant Escherichia coli Sequence Type 1642 Carrying an IncX3 Plasmid Containing the blaKPC-2 Gene Associated with Transposon Tn4401a by 이경원 et al.
ISSN 2234-3806 • eISSN 2234-3814 
https://doi.org/10.3343/alm.2018.38.1.17 www.annlabmed.org  17




Extensively Drug-Resistant Escherichia coli Sequence 
Type 1642 Carrying an IncX3 Plasmid Containing the 
blaKPC-2 Gene Associated with Transposon Tn4401a 
Seri Jeong, M.D.1, Jung Ok Kim, B.S.2, Eun-Jeong Yoon, Ph.D.2, Il Kwon Bae, Ph.D.3, Woonhyoung Lee, M.D.1,  
Hyukmin Lee, M.D.2, Yongjung Park, M.D.4, Kyungwon Lee, M.D.2, and Seok Hoon Jeong, M.D.2
Department of Laboratory Medicine1, Kosin University College of Medicine, Busan; Department of Laboratory Medicine and Research Institute of Bacterial 
Resistance2, Yonsei University College of Medicine, Seoul; Department of Dental Hygiene3, College of Medical and Life Science, Shilla University, Busan;  
Department of Laboratory Medicine4, National Health Insurance Service Ilsan Hospital, Ilsan, Korea
Background: Extensively drug-resistant (XDR) Enterobacteriaceae carrying the blaKPC gene 
have emerged as a major global therapeutic concern. The purpose of this study was to 
analyze the complete sequences of plasmids from KPC-2 carbapenemase-producing XDR 
Escherichia coli sequence type (ST) 1642 isolates.
Methods: We performed antimicrobial susceptibility testing, PCR, multilocus sequence 
typing (MLST), and whole-genome sequencing to characterize the plasmid-mediated KPC- 
2-producing E. coli clinical isolates. 
Results: The isolates were resistant to most available antibiotics, including meropenem, 
ampicillin, ceftriaxone, gentamicin, and ciprofloxacin, but susceptible to tigecycline and 
colistin. The isolates were identified as the rare ST1642 by MLST. The isolates carried four 
plasmids: the first 69-kb conjugative IncX3 plasmid harbors blaKPC-2 within a truncated 
Tn4401a transposon and blaSHV-11 with duplicated conjugative elements. The second 142-
kb plasmid with a multireplicon consisting of IncQ, IncFIA, and IncIB carries blaTEM-1b and 
two class 1 integrons. This plasmid also harbors a wide variety of additional antimicrobial 
resistance genes including aadA5, dfrA17, mph(A), sul1, tet(B), aac(3’)-IId, strA, strB, and 
sul2. 
Conclusions: The complete sequence analysis of plasmids from an XDR E. coli strain re-
lated to persistent infection showed the coexistence of a blaKPC-2–carrying IncX3-type plas-
mid and a class 1 integron-harboring multireplicon, suggesting its potential to cause out-
breaks. Of additional clinical significance, the rare ST1642, identified in a cat, could con-
stitute the source of human infection.
Key Words: Escherichia coli, ST1642, blaKPC, Tn4401a, IncX3
Received: April 24, 2017
Revision received: May 29, 2017
Accepted: September 7, 2017
Corresponding author: Seok Hoon Jeong
Department of Laboratory Medicine and 
Research Institute of Bacterial Resistance, 
Gangnam Severance Hospital, Yonsei 
University College of Medicine, 211 Eonju-




© Korean Society for Laboratory Medicine
This is an Open Access article distributed under 
the terms of the Creative Commons Attribution 
Non-Commercial License (http://creativecom-
mons.org/licenses/by-nc/4.0) which permits 
unrestricted non-commercial use, distribution, 
and reproduction in any medium, provided the 
original work is properly cited.
INTRODUCTION
Klebsiella pneumoniae carbapenemase (KPC) is the most com-
mon class A carbapenemase in the world; the extensive spread 
of KPC-producing Enterobacteriaceae has become a major ther-
apeutic concern in clinical settings [1]. To date, a total of 21 KPC 
variants (KPC-2 to KPC-22) have been identified; of these, KPC-2 
and KPC-3 are the most prevalent [1]. KPCs are found predom-
inately in K. pneumoniae and less frequently in Escherichia coli 
[1, 2]. Similar to other acquired antimicrobial resistance deter-
minants, the blaKPC gene is disseminated by two means: 1) clonal 
spread of bacteria carrying the gene, and 2) horizontal transfer 
of the gene carried on mobile elements such as plasmids and 
transposons [1, 2]. 
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Molecular epidemiological studies on KPC-producing E. coli 
by multilocus sequence typing (MLST) have revealed that se-
quence type (ST) 131 strains are the most pervasive, followed 
by ST410, and less frequently ST69, ST93, ST167, ST354, and 
ST3948 strains [3-6]. In E. coli isolates, both blaKPC-2 and blaKPC-3 
genes are prevalent, while blaKPC-8 is rarely identified [4]. The 
blaKPC-2 gene is carried by IncFIA-, IncFIIk-, IncN-, and IncA/C-
type plasmids in the USA; IncN-, IncA/C- and IncF-type plas-
mids in China; an IncFIIA-type plasmid in France; an IncFIIk-
type plasmid in Greece; and IncFIIs-, IncN-, and IncHI2- plas-
mids in Israel; while the blaKPC-3 gene is associated with IncFIA-, 
IncFIIk-, IncN-, and IncA/C-type plasmids in the USA; an Inc-
FIIk-type plasmid in Italy; IncFII-, IncA/C-, and ColE-type plas-
mids in Spain; and IncFIIs-, IncN-, and IncHI2-plasmids in Is-
rael [4, 6]. Although an IncX3-type plasmid is prevalent in K. 
pneumoniae carrying the blaKPC gene [7], it has rarely been re-
ported in E. coli. 
The highly mobile Tn3-based transposon Tn4401 facilitates 
dissemination of the blaKPC gene [8]. Tn4401 is comprised of 
tnpA (transposase), tnpR (resolvase), and two insertion sequences 
(ISs), ISKpn7 and ISKpn6, as well as the blaKPC gene. The 10-kb 
transposon has 39-bp imperfect left- and right-inverted repeats 
and is flanked by 5-bp direct repeats [9]. Seven Tn4401 iso-
forms, Tn4401a to Tn4401g, have been identified; these are 
differentiated based on the size (68- to 255-bp) of the deletion 
between ISKpn7 and blaKPC compared with the prototype Tn4401b 
[10]. 
Here, we investigated the plasmids present in KPC-producing 
E. coli clinical isolates to elucidate the mechanisms underlying 
the acquisition of multi-drug resistance, including resistance to 
carbapenems. 
METHODS
1. Patient description 
An 85-year-old woman with a history of hypertension was trans-
ferred from Hyemin general hospital (Seoul, Korea) to Gangnam 
Severance hospital (Seoul, Korea) in January 2014 for the man-
agement of her cerebral hemorrhage. Brain computed tomogra-
phy and magnetic resonance imaging revealed a subacute in-
tracerebral hemorrhage in the right thalamus. The patient com-
plained of urinary frequency and retention, and a fever of over 
38.6°C developed on the 8th day post admission. An E. coli iso-
late (EcU443) was recovered from a urinary specimen on the 
8th day, and subsequent E. coli isolates (EcU213 on the 18th 
day and EcU120 on the 42nd day) were serially recovered from 
urinary specimens. 
2. Bacterial isolates and antimicrobial susceptibility testing
This study involved two E. coli clinical isolates, EcU443 and 
EcU120, serially recovered from urinary specimens of a patient 
with a 34-day interval. The isolates were identified as E. coli by 
matrix-assisted laser desorption ionization-time of flight mass 
spectrometry (Bruker Daltonics GmbH, Leipzig, Germany). Anti-
microbial susceptibilities were determined using VITEK 2 AST 
N211 cards (bioMérieux Vitek Inc., Hazelwood, MO, USA) and 
disk diffusion tests on Mueller-Hinton agar (Oxoid Ltd., Basing-
stoke, UK) according to the CLSI guidelines [11]. Carbapene-
mase production was confirmed using the KPC+MBL Confirm 
ID Kit (Rosco Diagnostica, Taastrup, Denmark) with tablets con-
taining meropenem (10 μg) alone or supplemented with dipico-
linic acid (1,000 μg), phenylboronic acid (400 μg), and cloxacil-
lin (750 μg) [12]. 
3. Genotyping of β-lactamases
The genomic DNA of each isolate was extracted by the boiling 
lysis method [13]. PCR was performed to detect genes encod-
ing extended-spectrum β-lactamases (CTX-M-1-, CTX-M-9-, TEM-, 
and SHV-type) and carbapenemases (IMP-1-type, VIM-2-type, 
NDM, KPC, GES, and OXA-48-like), as previously described [14]. 
Both strands of the amplicons were sequenced using an auto-
matic sequencer (model 3730xl; Applied Biosystems, Weiterstadt, 
Germany), and the nucleotide sequences were compared using 
the Basic Local Alignment Search Tool (BLAST; http://blast.ncbi.
nlm.nih.gov/Blast).
4. Multilocus sequence typing
MLST was carried out using partial sequences of seven E. coli 
housekeeping genes, including adk, fumC, gyrB, icd, mdh, purA, 
and recA. Nucleotide sequences were compared with those in 
the MLST database (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli) to 
identify allelic types and STs.
5. Bacterial conjugation
E. coli strain EcU443 was used as the donor and sodium azide-
resistant E. coli J53 was used as the recipient for the standard 
agar mating method [15]. Following overnight mating at 37°C 
on brain-heart infusion (BHI; MB cell, Los Angeles, CA, USA) 
agar, transconjugants were selected on BHI supplemented with 
100 μg/mL sodium azide and 0.5 μg/mL imipenem. 
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6. Whole genome sequencing 
The complete DNA sequences of the plasmids present in EcU443 
were obtained via Single-Molecule Real-Time sequencing on a 
PacBio RSII instrument (Pacific Biosciences, Menlo Park, CA, 
USA), according to the manufacturer’s instructions. The sequen-
ces were annotated using Prokka 1.11 (http://www.vicbioinfor-
matics.com/software.prokka.shtml). Resistance genes, IS ele-
ments, replication origins, virulent elements, and toxins and anti-
toxin systems were identified using ResFinder (https://cge.cbs.
dtu.dk//services/ResFinder/), IS-finder (https://www-is.biotoul.
fr/), plasmid finder (https://cge.cbs.dtu.dk//services/Pla-smid-
Finder/), the Virulence Factor Database (http://www.mgc.ac.cn/
VFs/), and TA Finder 1.0 (http://202.120.12.133/TAfinder/index.
php), respectively. 
7. GenBank accession numbers
Nucleotide sequence data for plasmids pECSEV_01 and pECSEV_ 
02 are available under GenBank accession numbers KX683283 
and KX683284, respectively.
RESULTS
1. Antimicrobial susceptibilities and molecular typing
The antimicrobial susceptibility profiles of the clinical E. coli 
strains are presented in Table 1. The isolates exhibited resis-
tance to most antibiotics tested, including meropenem, ampicil-
lin, ceftriaxone, gentamicin, and ciprofloxacin, but were suscep-
tible to tigecycline and colistin. Phenotypic carbapenemase dif-
ferentiation tests showed positive results for KPC production in 
both isolates (EcU443 and EcU120; Table 2). The MLST assay 






EcU443† EcU213† EcU120† EcU443 EcU120
AMP ≥32 ≥32 ≥32 AMP   6 10 R
SAM ≥32 ≥32 ≥32 SAM   6   6 R
TZP ≥128 ≥128 ≥128 PIP 10 10 R
ATM ≥64 ≥64 ≥64 TIC 10 10 R
CAZ 4 4 16 CRO 15 16 R
GEN ≥16 ≥16 ≥16 GEN   7   7 R
LVX ≥8 ≥8 ≥8 CIP   6   6 R
CFZ ≥64 ≥64 ≥64 IMP 20 19 I
MEM ≥16 ≥16 ≥16 MEM 20 20 I
ERM 4 4 ≥8 ERM 17 17 R
CTM ≥320 ≥320 ≥320 CST 14 15 -
TGC ≤0.5 ≤0.5 ≤0.5 TGC 24 24 -
*The breakpoints were applied according to the Clinical and Laboratory Standards Institute (CLSI) guidelines; the resistance values are in bold; †EcU443, 
EcU213, and EcU120 were isolated on the 8th, 18th, and 42nd day post admission, respectively; ‡The EcU443 disk diffusion tests results were interpreted 
according to the CLSI guidelines; the results for colistin and tigecycline are not shown because of the lack of suggested breakpoints.
Abbreviations: AMP, ampicillin; ATM, aztreonam; CAZ, ceftazidime; CFZ, cefazolin; CIP, ciprofloxacin; CRO, ceftriaxone; CST, colistin; ERM, ertapenem; 
GEN, gentamicin; I, intermediate; IMP, imipenem; LVX, levofloxacin; MEM, meropenem; MIC, minimum inhibitory concentration; PIP, piperacillin; R, resis-
tant; SAM, ampicillin-sulbactam; SXT, trimethoprim-sulfamethoxazole; TGC, tigecycline; TIC, ticarcillin; TZP, piperacillin-tazobactam.
Table 2. Results of carbapenemase differentiation tests and sequence types of Escherichia coli isolates
E. coli  
   isolates*
Carbapenemase differentiation test MLST
MEM MEM+DPA MEM+PBA† MEM+CLX ST adk fumC gyrB icd mdh purA recA
EcU443 19 19 24 20 1642 6 4 5 18 11 8 6
EcU120 20 20 25 21 1642 6 4 5 18 11 8 6
*EcU443 and EcU120 were isolated on the 8th and 42nd day post admission, respectively; †A difference between MEM+PBA and MEM >5 mm indicated 
KPC production.
Abbreviations: CLX, cloxacillin; DPA, dipicolinic acid; MEM, meropenem; MLST, Multilocus sequence typing; PBA, phenylboronic acid.
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assigned both isolates as an identical ST1642 (6-4-5-18-11-8-
6). PCR and sequencing for β-lactamase genes demonstrated 
the presence of blaKPC-2, blaSHV-11, and blaTEM-1 in both isolates. 
2. Plasmids pECSEV_01 and pECSEV_02
E. coli strain EcU443 had a 4,769,071-bp chromosome and 
four plasmids. The chromosome did not contain any acquired 
antimicrobial resistance determinants. The 69,409-bp IncX3 
plasmid (pECSEV_01) carried blaKPC-2 and blaSHV-11 for β-lactam 
resistance; the 142,708-bp multireplicon (IncFIA, IncFIB, and 
IncQ) plasmid (pECSEV_02) included strA, strB, aadA5, and 
aac(3)-IId for aminoglycoside resistance, blaTEM-1b for β-lactam 
resistance, mph(A) for macrolide resistance, sul1 and sul2 for 
sulfonamide resistance, tet(B) for tetracycline resistance, and 
dfrA17 for trimethoprim resistance; and the 118,130-bp plas-
mid (pECSEV_03) harbored blaTEM-1b for β-lactam resistance and 
qnrS1 for quinolone resistance. Moreover, a cryptic 110,571-bp 
plasmid was also identified.
Plasmid pECSEV_01 carrying the blaKPC-2 gene belonged to 
the IncX3 group (Fig. 1). This plasmid could be transferred to 
recipient E. coli J53 by surface mating. The blaKPC-2 gene was lo-
cated within a truncated Tn4401 transposon; ΔISKpn7-blaKPC-2-
ISKpn6 had a 99-bp deletion between ISKpn7 and blaKPC indi-
cating it was a Tn4401a isoform. The plasmid also harbored the 
blaSHV-11 gene encoding a broad-spectrum β-lactamase. The rep-
lication origin repB gene belonged to the IncX3 incompatibility 
type. The remaining sections of pECSEV_01 consisted of dupli-
cated type IV secretion systems and conjugative elements. 
Plasmid pECSEV_02 possessed three replication origins for 
the IncFIA, IncFIB, and IncQ groups (Fig. 2). The plasmid car-
ried two identical copies of a class 1 integron, In54, containing 
the dhfrA17-aadA5-emrE gene cassettes for trimethoprim-, ami-
noglycosides-, and multidrug-resistance, as well as a truncated 
Tn3 transposon harboring blaTEM-1b. The macB, mph(A), aac(3)-
IId, strA, strB, and tet(B) drug resistance genes were also iden-
tified. In addition to drug-resistance determinants, pECSEV_02 
also included a virulence gene cluster containing the iucA, iucB, 
iucC, iucD, and iutA genes involved in hydroxamate siderophore 
aerobactin synthesis and two toxin/antitoxin systems, vapBC and 
ccdAB. 
Fig. 1. Circular map of pECSEV_01 containing blaKPC-2, blaSHV-11, and duplicated conjugative elements. 
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DISCUSSION
E. coli clinical isolates EcU443 and EcU120 were serially recov-
ered from urinary specimens of a patient with a 34-day interval. 
Both strains belong to ST1642, exhibit resistance or intermedi-
ate resistance to all classes of antimicrobial agents tested, ex-
cept for tigecycline and colistin, and possess the blaKPC-2, blaSHV-11, 
and blaTEM-1 β-lactamase genes, indicating that this clone was 
responsible for the persistent infection in the patient over the 34 
days. To the best of our knowledge, E. coli ST1642, first isolated 
from a pet cat as an extraintestinal pathogenic strain [16], has 
not been previously reported as a KPC-producer. Although ST131 
strains are the most frequently identified in KPC-producer E. coli 
infections [17], three cases of KPC-2-producer infections due to 
ST69, ST393, and a new E. coli ST were recently identified in 
Busan [18]. The three E. coli strains carried an IncX3 plasmid 
similar to that in our strains, although the E. coli strains were epi-
demiologically unrelated.
E. coli strain EcU443 possesses four plasmids. The blaKPC-2 
gene is on IncX3 plasmid pECSEV_01 containing the blaSHV-11 
gene. The plasmid showed 99% identity with IncX3 plasmid 
pKpS90 from a K. pneumoniae ST258 strain (GenBank acces-
sion number JX461340) isolated from a blood culture during a 
hospital outbreak in France [19]. In pECSEV_01, the truncated 
Tn4401a carrying the blaKPC-2 gene is integrated in the opposite 
direction, but at the same location as in pKpS90. The truncated 
Tn4401a has also been found in IncX3 plasmid pKPC_Kp01 
from a clinical K. pneumoniae isolate responsible for a hospital 
outbreak in Busan [18].
Plasmid pECSEV_02, containing multiple replicons of IncFIA, 
IncFIB, and IncQ, carries various genes conferring resistance to 
diverse classes of antimicrobial agents. Interestingly, pECSEV_02 
harbors two identical copies of class 1 integron In54. An Entero-
bacter cloacae strain carrying multiple non-identical class 1 in-
tegrons in a plasmid has been identified [20]. Plasmid pECSEV_ 
02 also carries genes for virulence factors and for toxin/antitoxin 
systems that can enhance bacterial fitness in a human host, thus 
explaining its long persistence in the patient. The third plasmid, 
pECSEV_03, also contributed to the extensively drug-resistant 
(XDR) E. coli via blaTEM-1b and qnrS1.
This study reports a persistent infection case caused by an 
XDR E. coli ST1642 strain carrying an IncX3 plasmid containing 
blaKPC-2 associated with a truncated Tn4401a transposon and a 
plasmid with multireplicons of IncQ, IncFIA, and IncFIB, which 
contains genes conferring resistance to multiple classes of anti-
microbial agents. Sporadic or epidemic infection cases caused 
by KPC-producers have been increasingly reported in Korea; the 
blaKPC genes are spreading to K. pneumoniae as well as other 
Fig. 2. Circular map of pECSEV_02 containing blaTEM-1, two class 1 integrons, virulence elements, and transconjugative elements. 
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species in the family Enterobacteriaceae, including E. coli, via R 
plasmids. Further studies are needed to investigate the current 
status of KPC-producers in Korea.
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